Evidence map›Paper›PMID 34663916›Full record

ArticleEuropean journal of human genetics : EJHG2022

Genomic health data generation in the UK: a 360 view.

Elizabeth Ormondroyd, Peter Border, Judith Hayward, Andrew Papanikitas

Open access · hybridAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Genomic medicine for the 21Annals of the Royal College of Surgeons of England · 2024
    Article
  8. Article
  9. 2022: the year that was in the European Journal of Human Genetics.European journal of human genetics : EJHG · 2023
    Article
  10. Core elements of participant consent documents for Canadian human genomics research and the National Human Genome Library: guidance for policy.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2022
    Article
  11. Clinical genomics testing: mainstreaming and globalising.European journal of human genetics : EJHG · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Elizabeth OrmondroydRadcliffe Department of Medicine, University of Oxford, Oxford, UK. liz.ormondroyd@cardiov.ox.ac.uk.ORCID http://orcid.org/0000-0002-9116-4064
Peter BorderParliamentary Office of Science and Technology, London, UK.
Judith HaywardHealth Education England Genomics Education Programme, London, UK.
Andrew PapanikitasNuffield Department of Primary Care Health Science, University of Oxford, Oxford, UK.
Chapel Allerton Hospital · GBNational Institute for Health Research · GBParliament of United Kingdom · GBUniversity of Oxford · GB

Funding

Department of HealthWellcome Trust
6 · The paper itself

Abstract

In the UK, genomic health data is being generated in three major contexts: the healthcare system (based on clinical indication), in large scale research programmes, and for purchasers of direct-to-consumer genetic tests. The recently delivered hybrid clinical/research programme, 100,000 Genomes Project set the scene for a new Genomic Medicine Service, through which the National Health Service aims to deliver consistent and equitable care informed by genomics, while providing data to inform academic and industry research and development. In parallel, a large scale research study, Our Future Health, has UK Government and Industry investment and aims to recruit 5 million volunteers to support research intended to improve early detection, risk stratification, and early intervention for chronic diseases. To explore how current models of genomic health data generation intersect, and to understand clinical, ethical, legal, policy and social issues arising from this intersection, we conducted a series of five multidisciplinary panel discussions attended by 28 invited stakeholders. Meetings were recorded and transcribed. We present a summary of issues identified: genomic test attributes; reasons for generating genomic health data; individuals' motivation to seek genomic data; health service impacts; role of genetic counseling; equity; data uses and security; consent; governance and regulation. We conclude with some suggestions for policy consideration.

Indexed as

GenomicsState MedicineGenetic CounselingGenetic TestingHumansUnited Kingdom

Identifiers

PMID34663916
PMCPMC8523282
OpenAlexW3205410648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.